Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery

  • Kim, Kyung Su (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Shin, Kyung Hwan (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Choi, Noorie (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Lee, Sea-Won (Department of Radiation Oncology, Seoul National University College of Medicine)
  • Received : 2016.02.25
  • Accepted : 2016.03.16
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Hypofractionated whole breast irradiation (HF-WBI) has been proved effective and safe and even better for late or acute radiation toxicity for early breast cancer. Moreover, it improves patient convenience, quality of life and is expected to be advantageous in the medical care system by reducing overall cost. In this review, we examined key randomized trials of HF-WBI, focusing on adequate patient selection as suggested by the American Society of Therapeutic Radiology and Oncology (ASTRO) guideline and the radiobiologic aspects of HF-WBI in relation to its adoption into clinical settings. Further investigation to identify the current practice pattern or cost effectiveness is warranted under the national health insurance service system in Korea.

Keywords

References

  1. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11. https://doi.org/10.1056/NEJM198107023050102
  2. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665-73. https://doi.org/10.1056/NEJM198503143121101
  3. Fisher CM, Rabinovitch R. Frontiers in radiotherapy for earlystage invasive breast cancer. J Clin Oncol 2014;32:2894-901. https://doi.org/10.1200/JCO.2014.55.1184
  4. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17. https://doi.org/10.1016/j.radonc.2005.01.005
  5. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7:467-71. https://doi.org/10.1016/S1470-2045(06)70699-4
  6. START Trialists' Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-41. https://doi.org/10.1016/S1470-2045(08)70077-9
  7. START Trialists' Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371:1098-107. https://doi.org/10.1016/S0140-6736(08)60348-7
  8. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013;14:1086-94. https://doi.org/10.1016/S1470-2045(13)70386-3
  9. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20. https://doi.org/10.1056/NEJMoa0906260
  10. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;81:59-68. https://doi.org/10.1016/j.ijrobp.2010.04.042
  11. Mowery YM, Blitzblau RC. Whole-breast radiation therapy: the long and short of it. Int J Radiat Oncol Biol Phys 2014;90:990-2. https://doi.org/10.1016/j.ijrobp.2014.10.028
  12. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breastconserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:1707-16. https://doi.org/10.1016/S0140-6736(11)61629-2
  13. Trans-Tasman Radiation Oncology Group. Radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (DCIS) [Internet]. Waratah, Australia: Trans-Tasman Radiation Oncology Group; c2016 [cited 2016 Feb 17]. Available from: https://clinicaltrials.gov/ct2/show/NCT00470236.
  14. Lalani N, Paszat L, Sutradhar R, et al. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 2014;90:1017-24. https://doi.org/10.1016/j.ijrobp.2014.07.026
  15. Nilsson C, Valachis A. The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a metaanalysis of observational studies. Radiother Oncol 2015;114:50-5.
  16. Bane AL, Whelan TJ, Pond GR, et al. Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Ann Oncol 2014;25:992-8. https://doi.org/10.1093/annonc/mdu090
  17. Herbert C, Nichol A, Olivotto I, et al. The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort study. Int J Radiat Oncol Biol Phys 2012;82:2086-92. https://doi.org/10.1016/j.ijrobp.2011.01.055
  18. Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer: a review. Acta Oncol 2006;45:280-4. https://doi.org/10.1080/02841860500371907
  19. Badiyan SN, Shah C, Arthur D, et al. Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies. Radiother Oncol 2014;110:39-44. https://doi.org/10.1016/j.radonc.2013.12.006
  20. Kim JY, Jung SY, Lee S, et al. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer. Int J Radiat Oncol Biol Phys 2013;87:1037-42. https://doi.org/10.1016/j.ijrobp.2013.09.019
  21. Yarnold J. Hypofractionation, rationale, current status and futuredirections. In: ASTRO's 56th Annual Meeting; 2014 Sep 14-17; San Francisco, CA. Fairfax, VA: American Society for Radiation Oncology; 2014.
  22. Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011;79:1-9. https://doi.org/10.1016/j.ijrobp.2010.08.035
  23. Appelt AL, Vogelius IR, Bentzen SM. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol) 2013;25:147-52. https://doi.org/10.1016/j.clon.2012.07.012
  24. Tanguturi SK, Bellon JR. Hypofractionation for early-stage breast cancer: no more excuses. JAMA Oncol 2015;1:941-2. https://doi.org/10.1001/jamaoncol.2015.2605
  25. Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patientreported outcomes in a large multicenter cohort. JAMA Oncol 2015;1:918-30. https://doi.org/10.1001/jamaoncol.2015.2590
  26. Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol 2015;1:931-41. https://doi.org/10.1001/jamaoncol.2015.2666
  27. van der Laan HP, Hurkmans CW, Kuten A, Westenberg HA; EORTC-ROG Breast Working Party. Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 2010;94:280-5. https://doi.org/10.1016/j.radonc.2009.12.032
  28. Wang EH, Mougalian SS, Soulos PR, et al. Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: a National Cancer Data Base analysis. Int J Radiat Oncol Biol Phys 2014;90:993-1000. https://doi.org/10.1016/j.ijrobp.2014.06.038
  29. Jagsi R, Falchook AD, Hendrix LH, Curry H, Chen RC. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Int J Radiat Oncol Biol Phys 2014;90:1001-9. https://doi.org/10.1016/j.ijrobp.2014.09.032
  30. Chapman BV, Rajagopalan MS, Heron DE, Flickinger JC, Beriwal S. Clinical pathways: a catalyst for the adoption of hypofractionation for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2015;93:854-61. https://doi.org/10.1016/j.ijrobp.2015.08.013

Cited by

  1. Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features vol.7, pp.49, 2016, https://doi.org/10.18632/oncotarget.11702
  2. Displacement of Surgical Clips during Postoperative Radiotherapy in Breast Cancer Patients Who Received Breast-Conserving Surgery vol.19, pp.4, 2016, https://doi.org/10.4048/jbc.2016.19.4.417
  3. Possible benefits from post-mastectomy radiotherapy in node-negative breast cancer patients: a multicenter analysis in Korea (KROG 14-22) vol.8, pp.35, 2016, https://doi.org/10.18632/oncotarget.16241
  4. Could radiotherapy be omitted in elderly patients receiving breast conserving surgery? vol.33, pp.9, 2016, https://doi.org/10.1080/03007995.2017.1335190
  5. In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model vol.23, pp.18, 2016, https://doi.org/10.1158/1078-0432.ccr-17-0438
  6. Seroma change during magnetic resonance imaging-guided partial breast irradiation and its clinical implications vol.12, pp.None, 2016, https://doi.org/10.1186/s13014-017-0843-7
  7. Should age impact breast cancer management in young women? Fine tuning of treatment guidelines vol.10, pp.None, 2016, https://doi.org/10.1177/1758835918776923
  8. Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? vol.21, pp.2, 2018, https://doi.org/10.4048/jbc.2018.21.2.206
  9. Breast-conserving radiotherapy with simultaneous integrated boost; field-in-field three-dimensional conformal radiotherapy versus inverse intensity-modulated radiotherapy – A dosimetric compari vol.7, pp.3, 2016, https://doi.org/10.4103/sajc.sajc_82_18
  10. Practical consensus recommendations regarding role of postmastectomy radiation therapy vol.7, pp.2, 2016, https://doi.org/10.4103/sajc.sajc_108_18
  11. Evaluation of tissue computed tomography number changes and dosimetric shifts after conventional whole-breast irradiation in patients undergoing breast-conserving surgery vol.40, pp.8, 2016, https://doi.org/10.1177/1010428318791882
  12. Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold vol.13, pp.1, 2016, https://doi.org/10.1186/s13014-018-1079-x
  13. Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis vol.51, pp.1, 2019, https://doi.org/10.4143/crt.2018.163
  14. Results of a nationwide survey on Japanese clinical practice in breast-conserving radiotherapy for breast cancer vol.60, pp.1, 2016, https://doi.org/10.1093/jrr/rry095
  15. Breast-Conserving Radiotherapy with Simultaneous Integrated Boost-A Dosimetric Comparison of 3DCRT, VMAT and IMRT: Do We Really have a Better Plan? vol.17, pp.2, 2016, https://doi.org/10.1007/s40944-019-0289-y
  16. Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams vol.196, pp.4, 2016, https://doi.org/10.1007/s00066-019-01555-1
  17. Young Women With Breast Cancer: Treatment, Care, and Nursing Implications vol.24, pp.2, 2020, https://doi.org/10.1188/20.cjon.139-147
  18. The Acute and Late Toxicities of MRI-Guided External Beam Partial Breast Irradiation Delivered Using a Once-Per-Day Regimen vol.11, pp.None, 2016, https://doi.org/10.3389/fonc.2021.649301